Drug · DIN 02246083
IPRAVENT
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 28, 2017; first marketed December 3, 2002.
- Drug Identification Number (DIN)
- 02246083
- Company (DIN owner)
- AA Pharma Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Nasal
- Therapeutic class (ATC)
- Ipratropium bromide R01AX03
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| IPRATROPIUM BROMIDE | 21 MCG | ACT |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 14, 2014: NOC 15499Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- July 10, 2002: NOC 601Abbreviated New Drug Submission (ANDS)
Other DINs named IPRAVENT
- DIN 02246084 · Marketed